ARQ - 092 , is a potent pan-Akt inhibitor which can inhibit tumor growth preclinically .
Is currently in Phase I clinical studies .
ARQ - 092 , is a potent pan-Akt inhibitor which can inhibit tumor growth preclinically and is currently in Phase I clinical studies .